TORONTO – Patients with amnestic mild cognitive impairment made significantly more errors during a complex test of driving skills and showed altered... More »
Patients with postoperative delirium have significantly worse preoperative short-term cognitive performance and significantly greater long-term cognit... More »
TORONTO – A highly anticipated phase III trial of an anti-tau drug has posted negative topline results, conferring no cognitive or functional benefi... More »
TORONTO – A highly anticipated phase III trial of an anti-tau drug has posted negative topline results, conferring no cognitive or functional benefi... More »
Alzheimer’s Association chief public policy officer Robert Egge discusses the implications of the $1.4 billion proposed 2017 budget for Alzheimer’... More »
TORONTO – The annual Medicare wellness visit offers patients and their doctors the chance to review a variety of health concerns, and includes a cog... More »
TORONTO – In 2013, Medicare spent $2.6 billion on potentially avoidable hospitalizations for patients with Alzheimer’s disease and other dementias... More »
TORONTO – A rare loss of function in a gene that influences gamma secretase trafficking has been found to reduce the risk of Alzheimer’s by up to ... More »
TORONTO – Hallucinations – especially auditory hallucinations – triple the risk that a risperidone-controlled Alzheimer’s patient with psychos... More »
WASHINGTON – Alzheimer’s disease symptoms can be managed with simple algorithms that include ruling out other physiologic concerns and making some... More »
